Medikadenta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 303,399 | 327,879 | 338,341 | 487,532 | 502,028 | 507,284 | 658,979 | 625,626 |
| Profit before tax | - | - | - | - | - | - | 138,569 | 116,409 |
| Net profit | 69,233 | 76,074 | 78,577 | 146,327 | 60,498 | 54,848 | 118,090 | 97,784 |
| Equity | 72,366 | 83,733 | 123,255 | 171,931 | 80,661 | 60,213 | 137,126 | 118,775 |
| Liabilities | 58,389 | 63,669 | 90,597 | 97,501 | 72,477 | 57,658 | 38,018 | 17,642 |
| Non-current assets | 110,707 | 105,362 | 118,363 | 89,530 | 57,582 | 43,604 | 91,698 | 74,387 |
| Current assets | 20,048 | 42,040 | 95,489 | 179,902 | 95,556 | 74,267 | 83,446 | 62,030 |
| Total assets | 130,755 | 147,402 | 213,852 | 269,432 | 153,138 | 117,871 | 175,144 | 136,417 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 66,148 | 72,494 | 89,960 |
| Social insurance contributions | - | - | - | - | - | 54,286 | 64,687 | 64,605 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +45.3% | +8.1% | +3.2% | +44.1% | +3.0% | +1.0% | +29.9% | -5.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 52.9% | 51.6% | 36.7% | 54.3% | 39.5% | 46.5% | 67.4% | 71.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 95.7% | 90.9% | 63.8% | 85.1% | 75.0% | 91.1% | 86.1% | 82.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 22.8% | 23.2% | 23.2% | 30.0% | 12.1% | 10.8% | 17.9% | 15.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 21.0% | 18.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 0.8 | 0.7 | 0.6 | 0.9 | 1.0 | 0.3 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 27,792 | 30,266 | 29,421 | 41,200 | 36,511 | 36,235 | 47,070 | 44,423 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medikadenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 16.74 |
| 2026-07-19 | 2026-07-20 | 110.35 |
| 2026-07-16 | 2026-07-17 | 110.35 |
| 2026-06-16 | 2026-06-18 | 68.60 |
| 2025-11-18 | 2025-12-08 | 10.58 |
| 2025-10-23 | 2025-11-06 | 0.18 |
| 2025-10-16 | 2025-10-19 | 97.73 |
| 2025-09-16 | 2025-10-02 | 2.41 |
| 2025-09-07 | 2025-09-08 | 0.78 |
| 2025-08-31 | 2025-09-03 | 0.78 |
| 2025-08-19 | 2025-08-29 | 0.78 |
| 2025-07-28 | 2025-08-07 | 27.90 |
| 2025-07-26 | 2025-07-27 | 27.39 |
| 2025-07-24 | 2025-07-25 | 27.90 |
| 2025-07-16 | 2025-07-23 | 27.39 |
| 2025-06-17 | 2025-07-07 | 0.28 |
| 2025-05-16 | 2025-06-04 | 55.20 |
| 2025-05-04 | 2025-05-12 | 28.10 |
| 2025-04-30 | 2025-04-30 | 27.11 |
| 2025-04-24 | 2025-04-29 | 28.10 |
| 2025-04-16 | 2025-04-23 | 27.11 |
| 2025-02-18 | 2025-02-20 | 919.36 |
| 2023-11-16 | 2023-12-10 | 30.17 |
| 2022-12-19 | 2022-12-19 | 2614.59 |
| 2022-12-16 | 2022-12-18 | 2719.59 |
| 2022-05-17 | 2022-05-18 | 62.92 |
| 2022-04-25 | 2022-05-10 | 0.18 |
| 2022-04-19 | 2022-04-20 | 62.71 |
| 2022-03-16 | 2022-03-17 | 62.70 |
| 2022-02-17 | 2022-02-20 | 62.83 |
| 2022-01-28 | 2022-02-14 | 0.12 |
| 2022-01-18 | 2022-01-19 | 46.16 |
| 2021-12-16 | 2021-12-19 | 54.95 |
| 2021-11-18 | 2021-12-06 | 2.97 |
| 2021-11-16 | 2021-11-17 | 59.72 |
| 2021-10-18 | 2021-10-19 | 14.71 |
| 2021-09-16 | 2021-09-19 | 1983.25 |
Medikadenta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-31 | 2026-06-04 | 5.16 |
| 2026-05-06 | 2026-05-30 | 6.0 |
| 2026-05-01 | 2026-05-05 | 455.33 |
| 2026-04-22 | 2026-04-30 | 454.25 |
| 2026-04-17 | 2026-04-21 | 449.93 |
| 2026-02-21 | 2026-02-27 | 4.93 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medikadenta, UAB (code 302691530) is a Private Limited Liability Company engaged in dental practice care activities. In 2025, the company generated revenue of €625.6K, down 5.1% year on year, but still above the €507.3K recorded in 2023, which indicates solid two-year growth of 23.3%. Net profit in 2025 was €97.8K, lower than €118.1K in 2024 but still well above the €54.8K achieved in 2023. Profitability remained healthy, with a 15.6% profit margin in 2025 versus 17.9% in 2024 and 10.8% in 2023. The balance sheet strengthened over the period, although it contracted in 2025: total assets decreased to €136.4K from €175.1K in 2024, equity fell to €118.8K, and liabilities declined to €17.6K. The company’s equity ratio was 87.1% and debt-to-equity 0.15, reflecting a low leverage position. Asset turnover reached 4.59x, showing efficient use of assets. With revenue per employee of €44.7K and profit per employee of €7.0K, the business appears to operate with moderate productivity and strong profitability for 2025.